Intuitive Surgical, Inc. (ISRG) has been drawing investor attention with positive Q1 2024 earnings, robust growth, and significant expansion in procedures. Despite some market choppiness and looming competition, the company's da Vinci Robotic Surgical System continues to thrive, amplifying its robotic surgery prowess. Investor outlook remains optimistic, largely due to surges in stock price and the launch of a new robotic system. However, concerns around ISRG's returns on capital persist. Notably, the FDA clearance for the company’s next-gen system signals potential for further growth.
Intuitive Surgical ISRG News Analytics from Wed, 29 Nov 2023 08:00:00 GMT to Wed, 08 May 2024 13:12:00 GMT -
Rating 7
- Innovation 8
- Information 8
- Rumor 3
